Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • aquleaf
    Member
    • Mar 2010
    • 38

    #1

    Questions regarding ChIP sonication and ChIP-Seq on heterochromatin

    Hi all. I have a problem regarding ChIP sonication. We are culturing one type of cells in two different states. One state shows active transcription (say State A), while the other one shows decreased overall transcription activity (say State B). We found that State B cells were very difficult to be sheared by sonication. The common solutions in this situation are to increase sonication power and extend the sonication treatment. However, we suspect that even though enhanced sonication might generate more small fragments, these fragments might be from chromatin with destroyed protein-DNA structure. The amount of ChIPed DNA might not increase much or even decrease. Thus, it seems that increasing the cell amount might be a good choice. But, the problem is we want to compare the binding profile differences between two states. Is that OK if we use different cell amounts in ChIP of two states of cells?

    One more question. Is there anyway to perform ChIP-Seq on heterochromatin marks?

    Thanks a bunch! Any help will be greatly appreciated.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...